Clinical data of HLA-A2+ cancer patients included in the study
Patient no. . | Cancer . | Staging at diagnosis . | Treatment (year) . | Status in October 2005 . |
|---|---|---|---|---|
| 1 | Prostate | pT2c/N0/Mx | Surgery (2001) | Disease-free |
| 2 | Prostate | pT3c/N0/Mx | Surgery (2001) plus LH-RH analog | Disease-free |
| 3 | Prostate | pT0/N0/Mx micronodulh-rle | Surgery (2001) | Disease-free |
| 4 | Prostate | pT2c/pNx | Surgery (2001) | Disease-free |
| 5 | Prostate | pT3b/pNx | Surgery (2001) | Disease-free |
| 6 | Prostate | T1 | None (2002) | Dead from heart disease |
| 7 | Prostate | pT2c/N0 | Surgery (2002) | Disease-free |
| 8 | Prostate | pT3a/Nx/G1 | Surgery (2002) | Disease-free |
| 9 | Prostate | pT2c/Nx/Mx | Surgery (2002) | Disease-free |
| 10 | Prostate | pT3b/N1/G2 | Surgery (2002) plus LH-RH analog | Relapse |
| 11 | Prostate | pT3a/N0/G2 | Surgery (2002) | Disease-free |
| 12 | Prostate | pT2b/N0/G1 | Surgery (2003) | Disease-free |
| 13 | Prostate | pT2b/N0/G1 | Surgery (2003) | Disease-free |
| 14 | Prostate | pT2a/Nx/G1 | Surgery (2003) | Disease-free |
| 15 | Prostate | pT3a/pNx/Mx | Surgery (2003) | Disease-free |
| 16 | Prostate | pT2b/pN0/Mx | Surgery (2004) | Disease-free |
| 17 | Prostate | pT2c/pN0/Mx | Surgery (2005) | Disease-free |
| 18 | Prostate | pT2c/pN0/Mx | Surgery (2005) | Disease-free |
| 19 | Breast | T4N1M1 | Chemotherapy (2001) | Dead |
| 20 | Breast | T4N1M1 | Chemotherapy (2002) | Dead |
| 21 | Lung | T4N1M1 | Chemotherapy (2001) | Dead |
| 22 | Lung | T4N1M1 | Chemotherapy (2002) | Dead |
| 23 | Gastric | T4N1M1 | Chemotherapy (2001) | Dead |
| 24 | NHL | Stage 2 | Chemotherapy (2002) | Disease-free |
| 25 | NHL | Stage 4 | Chemotherapy (2002) | Disease-free |
| 26 | NHL | Stage 4 | Chemotherapy (2005) | Disease-free |
| 27 | Liver | T4 | None (2003) | Disease progression |
Patient no. . | Cancer . | Staging at diagnosis . | Treatment (year) . | Status in October 2005 . |
|---|---|---|---|---|
| 1 | Prostate | pT2c/N0/Mx | Surgery (2001) | Disease-free |
| 2 | Prostate | pT3c/N0/Mx | Surgery (2001) plus LH-RH analog | Disease-free |
| 3 | Prostate | pT0/N0/Mx micronodulh-rle | Surgery (2001) | Disease-free |
| 4 | Prostate | pT2c/pNx | Surgery (2001) | Disease-free |
| 5 | Prostate | pT3b/pNx | Surgery (2001) | Disease-free |
| 6 | Prostate | T1 | None (2002) | Dead from heart disease |
| 7 | Prostate | pT2c/N0 | Surgery (2002) | Disease-free |
| 8 | Prostate | pT3a/Nx/G1 | Surgery (2002) | Disease-free |
| 9 | Prostate | pT2c/Nx/Mx | Surgery (2002) | Disease-free |
| 10 | Prostate | pT3b/N1/G2 | Surgery (2002) plus LH-RH analog | Relapse |
| 11 | Prostate | pT3a/N0/G2 | Surgery (2002) | Disease-free |
| 12 | Prostate | pT2b/N0/G1 | Surgery (2003) | Disease-free |
| 13 | Prostate | pT2b/N0/G1 | Surgery (2003) | Disease-free |
| 14 | Prostate | pT2a/Nx/G1 | Surgery (2003) | Disease-free |
| 15 | Prostate | pT3a/pNx/Mx | Surgery (2003) | Disease-free |
| 16 | Prostate | pT2b/pN0/Mx | Surgery (2004) | Disease-free |
| 17 | Prostate | pT2c/pN0/Mx | Surgery (2005) | Disease-free |
| 18 | Prostate | pT2c/pN0/Mx | Surgery (2005) | Disease-free |
| 19 | Breast | T4N1M1 | Chemotherapy (2001) | Dead |
| 20 | Breast | T4N1M1 | Chemotherapy (2002) | Dead |
| 21 | Lung | T4N1M1 | Chemotherapy (2001) | Dead |
| 22 | Lung | T4N1M1 | Chemotherapy (2002) | Dead |
| 23 | Gastric | T4N1M1 | Chemotherapy (2001) | Dead |
| 24 | NHL | Stage 2 | Chemotherapy (2002) | Disease-free |
| 25 | NHL | Stage 4 | Chemotherapy (2002) | Disease-free |
| 26 | NHL | Stage 4 | Chemotherapy (2005) | Disease-free |
| 27 | Liver | T4 | None (2003) | Disease progression |